Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders.

Recs

0
Player Avatar OKwarrior (37.97) Submitted: 6/9/2014 1:42:44 AM : Underperform Start Price: $13.70 VNDA Score: +4.62

F score = 2
Z score = -1.1

NOT

Featured Broker Partners


Advertisement